Disease Comparison Results (show all mode) for Prostate irradiation and Lumiliximab ( ) Administration/Toxicity

Ads

Lumiliximab ( ) Administration/Toxicity

Found: 11 | Differences: 11

Prostate irradiation

Found: 17 | Differences: 17

Prostate irradiation and Lumiliximab ( ) Administration/Toxicity do not share any common findings.

Disease Mechanism & Classification
Drugs
DRUG/Anti CD23 Lymphocyte Antibody
DRUG/DNA Bioengineered Antibody (Imab/Umab/Omab)
DRUG/Genetically engineered/biological drug (example)
DRUG/Immune modulator drug (ex)
DRUG/Monoclonal antibody medication/mab (example)
DRUG/Monoclonal Derived Antibody
DRUG/Monoclonal Derived Imab type
DRUG-New drugs (listed only)
Process
PROCESS/Medication/Drug (CONFIRM dose/before treatment)
Treatment
Drug Dosage
DRUG/Injectable medication (parenteral)
DRUG/Investigational 2009
Clinical Manifestations
Signs & Symptoms
Indurated prostate
Bowel/Stool Incontinence
Dysuria
URINE Stream Weak Force Size decreased
Demographics & Risk Factors
Population Group
Man
Sex & Age Groups
Population/Adult Aged Only
Population/Adult/all
Population/Male
Population/Male-only/limit
Population/Man patient
Laboratory Tests
Abnormal Lab Findings
Prostate Specific Antigen/PSA (Lab)
Associated Diseases & Rule outs
Associated Disease & Complications
Anal Incontinence
Acute Urinary Retention
Disease Mechanism & Classification
Class
CLASS/Genital, male (category)
CLASS/Prostate disorder (ex)
Process
PROCESS/Radiation/ionizing/xray trauma (category)
Ads